HEMP Biosciences Inc., a wholly-owned subsidiary of WEED Inc. BUDZ, received its hemp cultivation license from the state of Arizona. The license will allow the company to cultivate, process and manufacture hemp for the production of low THC & CBD products.
Glenn E. Martin of WEED stated, "This is a turning point for WEED Inc and its global subsidiaries as we come out of Covid lockdowns to now develop our proprietary strains to serve the medicinal world of Cannabis."
HEMP BioSciences CEO, Jeffery Miller, stated: "We are excited to finalize the approval of this license from the state of Arizona. After 3 years of field testing, we're now allowed to expand operations to provide high-quality premium cannabidiol products to our customers."
HEMP BioSciences looks to manufacture flower, vapes for smoking & medicinal products (both pharma and non-pharma) to include low THC and hemp CBD pre-rolls, infused THC pre-rolls with kief and/ash as licenses allow.
The license will allow Hemp Biosciences to cultivate hemp on up to 100 acres of land in Arizona. The company plans to use this land to grow hemp strains that will be processed into CBD oil and other hemp-derived products.
"We believe that CBD, CBG, CBN and minor cannabinoids have the potential to help many people with a variety of health conditions," stated COO Nicole Breen, "We are committed to making our products accessible to as many people as possible, and this license will help us to do that."
The company also announced that Breen received her "Facility Agent" card, which will allow Breen to sell/buy direct from Arizona dispensaries.
Photo: Benzinga edit with photos by Matthias Zomer on Pexels and squarefrog on Pixabay
Related News
WEED Inc. Acquires Hempirical Genetics, With Over 250 Proprietary Cannabis & Hemp Strains For $750K
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.